Impact of great saphenous vein quality on clinical outcomes after CABG in the REGROUP Trial
J Cardiovasc Surg (Torino)
.
2024 Feb;65(1):79-81.
doi: 10.23736/S0021-9509.23.12916-8.
Epub 2023 Dec 21.
Authors
Ajami Gikandi
1
2
,
Jacquelyn Quin
3
,
Eileen M Stock
4
,
Ellen Dematt
4
,
Sameer Hirji
3
5
,
Miguel Haime
3
,
Kousick Biswas
4
,
Marco A Zenati
3
5
Affiliations
1
Harvard Medical School, Division of Cardiac Surgery, Veterans Affairs (VA) Boston Healthcare System, Boston, MA, USA -
[email protected]
.
2
Harvard Medical School, Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, MA, USA -
[email protected]
.
3
Harvard Medical School, Division of Cardiac Surgery, Veterans Affairs (VA) Boston Healthcare System, Boston, MA, USA.
4
Office of Research and Development, USA Department of Veterans Affairs, VA Cooperative Studies Program Coordinating Center, Perry Point, MD, USA.
5
Harvard Medical School, Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, MA, USA.
PMID:
38127303
DOI:
10.23736/S0021-9509.23.12916-8
No abstract available
Publication types
Clinical Trial
MeSH terms
Coronary Artery Bypass / adverse effects
Coronary Artery Disease* / diagnostic imaging
Coronary Artery Disease* / surgery
Humans
Saphenous Vein*